ETFs1 source
Nasdaq Approves Listing of Canary’s Staked Injective ETF
Headline from The Defiant
Key points
- Nasdaq has approved the listing of Canary's Staked Injective exchange-traded fund, under the ticker INJC.
- The proposed fund plans to stake at least 90% of its total INJ holdings to earn rewards for investors.
- Additionally, the asset manager announced that the spot crypto product will charge an annual sponsor fee of 1.10%.
Summarized automatically by Kryptokite from reporting by The Defiant. Read the original sources for full detail.
Coins mentioned
Sources
- The DefiantNasdaq Approves Listing of Canary’s Staked Injective ETF · 1 hour agoRead on The Defiant
Story timeline
- CryptoPotato1 min read
ZEC Explodes by 13% Daily as BTC Price Reclaims $78K After Midterm Elections: Market Watch
- Crypto Briefing1 min read
Injective unveils Institutional Rail, a dedicated gateway for banks and funds
- The Defiant1 min read
Injective Introduces Priority Transaction Rail for Institutions
Share
Kryptokite links to the original reporting and never republishes full articles. Summaries are written automatically and may contain mistakes; nothing here is financial advice.